Scientists are employing AI to identify biological markers in the gut bacteria and immune systems of individuals suffering from chronic conditions like long Covid and myalgic encephalomyelitis (ME). The goal is to better understand and combat these debilitating diseases, which share symptoms such as persistent fatigue and cognitive dysfunction. Researchers are analysing vast datasets to pinpoint unique patterns and potential therapeutic targets. This approach could lead to earlier diagnosis, personalised treatments, and a better quality of life for those affected by these complex and often misunderstood conditions. By focusing on the biological underpinnings of fatigue, scientists hope to move beyond symptomatic relief and develop targeted interventions that address the root causes of these illnesses. The application of AI represents a significant step forward in the fight against long Covid and other fatigue-related diseases, offering hope for more effective treatments and ultimately, cures.
Subscribe for Weekly Updates
Stay ahead with our weekly AI and tech briefings, delivered every Tuesday.
